Tech Company Financing Transactions

Protagonist Therapeutics Funding Round

Johnson & Johnson Development Corporation, Lilly Ventures and Starfish Ventures participated in a $14 million Series B funding round for Protagonist Therapeutics. The financing was announced by the company on 6/5/2013.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

7707 Gateway Blvd. 140
Newark, CA 94560
USA

Phone

(510) 474-0170

Website

www.protagonist-inc.com

Email Address

[email protected]

Overview

Protagonist Therapeutics (NASDAQ: PTGX) is a biotechnology company pursuing the discovery and development of disulfide-rich peptides (DRPs) as well differentiated alternatives to biologics.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Dinesh Patel

        

Chief Financial Officer

Donald Kalkofen

        

Chief Medical Officer

Samuel Saks

        

Chief Scientific Officer

David Liu

        

VP - Bus. Development

Suneel Gupta

        

VP - Bus. Development

Tracy Woody

        

Browse more venture capital transactions:

Prev: 6/5/2013: Contour venture capital transaction
Next: 6/5/2013: Lantos Technologies venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary